Others have previously reported abundant IL-18 and caspase-1 plasmatic levels, as well as elevated mRNA levels for the same factors in the lesional skin of CTCL patients [19]. The gene discussed is CASP1; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.